ALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Malignant Mesothelioma.

This treatment has been approved for sale to the public.

Study NCT00040625 Information provided by Eli Lilly and Company

First Received: July 2, 2002 Last Updated: March 14, 2007 History of Changes

No Study Results Posted for this Study

Study Status:	This treatment has been approved for sale to the public.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given